Description: Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. It operates allergy, arrhythmia, behavioral health, breast, home service, heart valve, robotic surgery, rehabilitation, children's, colorectal surgery, complex coronary artery intervention, cornea transplant, dental, diagnostic, dialysis, digestive disease, ear, nose, throat, emergency, endocrinology, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopedics, perinatal, plastic surgery, pulmonary, refractive surgery, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, comprehensive sleep, IVF, hearing and balance, medical, memory, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, vaccine clinics. In addition, it provides spine institute, diagnostic radiology and nuclear medicine, esperance, heart institute, intensive care unit, neurocritical care, nutrition services, pharmacy services, and preventive genomics and integrative medicine services. Further, the company offers clinical research; hospital consulting and management; healthcare personnel development and training; healthcare referral; and digital platform services. Additionally, it is involved in the distribution of pharmaceutical and medical goods in specialized stores; development of software for healthcare services; holding of real estate assets; and manufacture and sale of vitamin supplements. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.
Home Page: www.bumrungrad.com
33 Sukhumvit Soi 3 (Nana Nua)
Bangkok,
10110
Thailand
Phone:
66 2 066 8888
Officers
| Name | Title |
|---|---|
| Ms. Linda Lisahapanya | President, MD & Executive Director |
| Ms. Artirat Charukitpipat | Chief Executive Officer |
| Ms. Oraphan Buamuang CPA | Chief Financial Officer |
| Dr. Nipat Kulabkaw | Chief Operating Officer |
| Ms. Supawan Sirinuntawit | Accounting Manager |
| Dr. Polakit Teekakirikul M.D. | Chief Science Officer |
| Mr. Daniel Kastner | Chief Transformation Office & Head of IR |
| Dr. Aniello M. Sorrentino Ph.D. | Corporate Chief Strategy Officer |
| Mr. David T. Boucher FACHE, M.P.H. | Chief Business Transformation Officer |
| Tanee Maneenut | Chief Business Development Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Facilities |
| Forward PE: | 20.4918 |
|---|---|
| Trailing PE: | 23.75 |
| Price-to-Book MRQ: | 6.4165 |
| Price-to-Sales TTM: | 0.1798 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |